In July 2023, the team of Professor Li Leping and Professor Liang Shang at Shandong Provincial Hospital Affiliated to Shandong First Medical University successfully completed the world's first (and second) pure single-port robotic radical total gastrectomy (SPRTG) using the domestically produced Shurui® SR-ENS-600 single-port robotic system. This study, authored by Liang Shang, Li Leping, and team members from the hospital's Department of Gastrointestinal Surgery, was published in the Chinese Medical Journal.

The findings of the world's first exploratory study (FUTURE-05) on distal gastrectomy using the Shurui® SR-ENS-600 single-port robot have been officially published in Surgical Endoscopy, the official journal of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).

On April 14, the Urology Department team led by Professor Yang Jie at Jiangsu Cancer Hospital (Jiangsu Cancer Center) successfully completed the world's first single-port robot-assisted laparoscopic renal artery aneurysm resection with renal artery reconstruction.

The 93rd CMEF has concluded. At this exhibition, Shurui® sent an even clearer and more definitive signal: minimally invasive surgery is entering a new phase of upgrading to single-port techniques, and Chinese surgical robotics is entering a new phase of competition centered on direction.

Recently, the Urology Department of Fujian Medical University Union Hospital, led by Professor Zhu Shaoxing, successfully performed a left adrenal pheochromocytoma resection on a patient using a domestic single-port robotic surgical system.

From March 20 to 22, 2026, the 2026 Annual Conference of the Gynecologic Minimally Invasive Surgery Branch of Shandong Medical Doctor Association was grandly held in Jinan, the "City of Springs." The conference focused on cutting-edge fields including general gynecology, gynecologic oncology, and gynecologic endocrinology, bringing together top experts and scholars from across China.

Recently, the Pediatric Surgery team at Guangzhou Women and Children's Medical Center Liuzhou Hospital successfully performed radical surgery and biliary reconstruction on a 1-month-old infant weighing only 3.3 kg with a choledochal cyst using a single-port surgical robot.

On March 18-19, the team led by Professor Li Zhigang from the Department of Thoracic Surgery at Shanghai Chest Hospital successfully completed two consecutive cases of China's first snake-arm single-port robot-assisted pure subcostal single-port right lower lobectomy for lung cancer.

On the morning of March 11, 2026, a landmark clinical trial commenced simultaneously at the Jiangjiayuan Campus and the Maigaoqiao Campus of the Second Affiliated Hospital of Nanjing Medical University – the "Single-Center, Multi-Campus 5G Remote Surgery Using a Single-Port Surgical Robot" project was officially launched.

On January 22, 2026, Professor Zheng Ying's team from the Department of Gynecology at West China Second University Hospital of Sichuan University successfully performed a transumbilical single-port uterine manipulator-free radical hysterectomy for cervical cancer using the Shurui® snake-arm surgical robot.

For a long time, urology has been one of the most mature and fiercely competitive fields for surgical robot applications. It encompasses a wide variety of surgical procedures, confronts complex and delicate anatomical structures, and demands exceptional precision, stability, and operational freedom from the surgical platform. The ability to perform reliably in high-difficulty urologic oncology surgeries is the key test of a surgical robot's true capability.

On February 9, during his first local inspection tour in the opening year of the 15th Five-Year Plan, General Secretary Xi Jinping visited the National Information Technology Application Innovation Park in Beijing E-Town. He focused on information technology application innovation and the construction of an international scientific and technological innovation center, pointing the way for China's self-reliance and strength in science and technology.

To overcome this technological bottleneck, the National Center for Children's Health (Beijing Children's Hospital) has established an in-depth strategic cross-disciplinary medical-engineering collaboration with Shurui® Robot.  The goal of this partnership is clear: through close strategic cooperation, to develop robotic technology better suited to children's physiological characteristics, validate its clinical value in complex pediatric surgeries, and ultimately provide young patients with more precise, minimally invasive, and safer treatment options.  

An incision of just 2.5 centimeters, the size of a coin, serves as the gateway into the depths of the human body. Through this tiny opening, three bionic snake-like instruments perform intricate procedures within the patient's abdominal cavity, successfully completing a pancreaticoduodenectomy — a procedure often regarded as the "Mount Everest" of abdominal surgery.

Recently, the team led by Professor Liu Wei from the Department of Gynecology at Shandong Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital) successfully completed the first case in East China of tubal reanastomosis after ligation using a domestically developed single-port surgical robot. This procedure further advances the innovation of minimally invasive tubal surgery technology in the province.

Shanghai Ruijin Smart Medical Consortium | Smart Medicine Combined with a Single-Port Surgical Robot Opens a “Green Fast Track to Recovery” for Kidney Cancer Patients

A Surgeon's "Magic Hands" Help a Patient Transition from Hardship to Renewal: This Hospital Helps a 39-Year-Old Fitness Coach Rebuild Both Her Life and Career

On December 24, the inauguration ceremony for the Beijing Shurui Surgical Robotics Innovation Demonstration Center and the signing ceremony between Peking University Shougang Hospital and a robotics leasing company were held.

In December 2025, Beijing Surgerii Robotics Company Limited (hereinafter referred to as "Surgerii Robotics" or "the Company"), a leading innovator in the single-port endoscopic surgical robotics area, announced the closing of a USD100 million Series D financing. The funding round was led by Loyal Valley Capital, with participation from several renowned investors including Shanghai Healthcare Capital, V Star Capital, DNV Capital, and Hefei Industrial Investment. The financing will advance the clinical adoption and market promotion of the Company’s core product, the SHURUI Single-Port Surgical Robot ("SHURUI SP Robot") both domestically and internationally, and accelerate the development of the Company’s next-generation products. This will further consolidate the Company’s pioneering position in the global single-port surgical robotics sector.

On August 28, 2025, Beijing Surgerii Robotics Company Limited made history as its SHURUI^® Single-Port Surgical Robot with snake-like instruments received its CE certification (MDR EU2017/745).

Strasbourg, France, July 16-20, 2025 – The Society of Robotic Surgery (SRS) conference, the most influential academic event in the field of robotic surgery, was held grandly in Strasbourg, France. Experts and scholars from over 30 countries gathered to explore future trends and technological innovations in robotic surgery.

Recently, the thoracic surgery team led by Directors Xiangnan Li and Jia Zhao at Zhengzhou University First Affiliated Hospital achieved a major milestone by performing 12 esophageal cancer radical resections using the SHURUI^® single-port surgical robot. This marks a significant breakthrough in minimally invasive esophageal cancer treatment in China.

At ATCCS 2025 in Hong Kong, Asia’s leading thoracic surgery summit, Surgerii Robotics unveiled its cutting-edge SHURUI^® single-port robot, becoming the only Chinese surgical robot brand invited to the event.

Surgerii Robotics has launched the SMRAT multicenter randomized controlled trial (RCT), in partnership with top Chinese institutions including Ruijin Hospital, Shandong Provincial Hospital, and others.

A surgical team at Peking University Shougang Hospital has successfully performed a complex liver resection for hepatocellular carcinoma using the SHURUI^® single-port surgical system, marking the first case of its kind in China. The patient, a 63-year-old male with cirrhosis and a centrally located liver tumor, was treated through a single 3–4 cm umbilical incision.

In June 2025, a delegation from Munich Clinic Bogenhausen—one of Southern Germany’s top teaching hospitals—visited China to explore clinical collaboration with Surgerii Robotics. Led by Prof.

In a major clinical milestone, Prof. Lu Jian’s urology team at Beijing Haidian Hospital successfully performed a total robot-assisted radical cystectomy using the SHURUI^® single-port system. The 75-year-old patient, diagnosed with recurrent muscle-invasive bladder cancer and ureteral involvement, underwent complete bladder and prostate removal with intracorporeal urinary reconstruction—all via a 3 cm umbilical incision.

In a regional milestone for minimally invasive thoracic surgery, Dr. Weijiang Huang and his team at Xiaogan Central Hospital successfully performed Central China’s first single-port robotic resection of a large anterior mediastinal tumor.

The Thoracic Surgery team at Ruijin Hospital, led by Prof. Hecheng Li, has successfully performed Shanghai’s first segmentectomy using the SHURUI^® single-port robotic system—marking a new milestone in precision thoracic surgery.

On June 16, the Guangzhou Women and Children’s Medical Center achieved a national first by performing a remote pediatric urologic procedure using the SHURUI^® single-port robotic system. Leveraging 5G connectivity, the surgical team operated across 500 kilometers to perform a complex reoperation for recurrent hydronephrosis in a 2.5-year-old patient.

On June 11, Peking University Shougang Hospital completed its first radical cystectomy using the SHURUI^® single-port robotic system—a major leap in minimally invasive urologic oncology.

Prof. Jianxing He’s team at Guangzhou Medical University First Affiliated Hospital has made a historic impact in robotic thoracic surgery.

In a regional first, Xiaogan Central Hospital successfully performed a laparoscopic distal gastrectomy for gastric cancer using the SHURUI^® single-port robotic system. Led by Dr.

At the inaugural Yangtze River Delta AI & Healthcare Innovation Conference, Suzhou First Affiliated Hospital and Surgerii Robotics were honored for their pioneering work in robotic thoracic surgery using China’s first single-port robotic system, SHURUI^®.

On May 9, during a live broadcast to 45,000 viewers at the inaugural Summit on Gynecologic Minimally Invasive Surgery and AI, Prof. Xiaoming Guan and Prof. Chunhua Zhang completed the world’s first vNOTES sacrocolpopexy assisted by the SHURUI^® single-port robotic system.

On April 16, Shanghai Children’s Hospital successfully performed the world’s first pediatric Ladd procedure using a single-port robotic system. The 5-year-old patient was diagnosed with congenital intestinal malrotation—a condition requiring precise, multi-step abdominal correction.

At the National Children's Medical Center in Shanghai, a 6-month-old infant diagnosed with a malignant testicular tumor was successfully treated using the SHURUI^® single-port surgical robot. This marked the 20th clinical procedure since the pediatric urology team at Shanghai Children's Medical Center adopted the domestically developed robotic platform earlier this year.

In a major breakthrough for thyroid and breast cancer care, Huashan Hospital of Fudan University successfully completed Shanghai's first single-port robotic breast cancer mastectomy with immediate reconstruction and the city’s first robotic thyroidectomy using the SHURUI^® system.

At the 10th East China OB-GYN Academic Conference, the SHURUI^® single-port robotic system emerged as a leading innovation in minimally invasive surgery. Endorsed by Prof. Jinghe Lang and Prof.

At the 2025 Sino-European Robotic Thoracic Surgery Forum in Shanghai, Surgerii Robotics took center stage with its SHURUI^® single-port surgical system, drawing strong attention from experts across China and Europe.

At Shanghai Children's Medical Center, a girl recently underwent a scar-free robotic splenectomy using the SHURUI^® single-port surgical system—marking her family’s third generation to battle hereditary spherocytosis with surgery.

On March 16, 2025, the Department of Obstetrics and Gynecology at Nanjing Medical University Second Affiliated Hospital successfully held its inaugural R-SUV single-port robotic surgery hands-on training class. This milestone event gathered over 30 leading gynecologic surgeons from across China to explore cutting-edge techniques and clinical applications of single-port robotic surgery.

Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, recently achieved a groundbreaking milestone. Led by Director Junwei Pan, the urology team completed the world’s first perineal urethral cancer radical surgery assisted by the innovative SHURUI^® single-port surgical robot.

In a series of firsts for Jiangsu Province, Nanjing Children's Hospital successfully completed three advanced pediatric procedures using the SHURUI^® single-port robotic system: pyeloplasty, ovarian cystectomy, and ureteral reimplantation in complex kidney anomalies.

On February 21, during a national gynecologic surgery forum in Nanjing, Prof. Chunhua Zhang’s team at the Second Affiliated Hospital of Nanjing Medical University successfully performed a robot-assisted vNOTES high sacrospinous ligament suspension using the SHURUI^® surgical system. The live-streamed procedure treated a 67-year-old patient suffering from advanced uterine prolapse.

On February 20, the OB-GYN team at International Peace Maternity & Child Health Hospital successfully performed its first domestic single-port robot-assisted laparoscopic surgery using teh SHURUI^® single-port surgical robot —a minimally invasive ovarian teratoma resection in a young female patient.

On February 15-16, 2025, the “Robotic Biliary Surgery Symposium: Collision and Integration of Da Vinci and Domestic Robots” was successfully held in Guiyang, gathering over 30 leading experts and 23 renowned institutions worldwide. The event showcased the latest robotic applications in biliary surgery through live streaming and in-person exchanges.

On January 24, Nanjing Children’s Hospital successfully performed Jiangsu’s first single-port robotic-assisted laparoscopic high ligation of the internal spermatic vein, marking a new era of ultra-minimally invasive pediatric surgery at the hospital.

Xiaogan Central Hospital recently introduced the globally advanced SHURUI^® single-port surgical robot, marking a milestone in minimally invasive surgery and the commercial adoption of high-end domestic medical technology in a prefecture-level hospital.

Date: May 6, 2025, The Surgerii^® Single-Port Robotic System has received approval from China’s National Medical Products Administration (NMPA) for expanded indications (Registration No.: GuoXieZhuZhun 20233010833). Its scope now covers “urology, gynecology, general surgery, and thoracic surgery (lung procedures) under physician-controlled master-slave manipulation for minimally invasive surgical operations.” 

On April 23, 2025, the signing ceremony for the Letter of Intent on Scientific Research Collaboration and Technology Transfer between Peking Union Medical College Hospital (PUMCH) and Shurui Robotics Innovation Demonstration Center was held in Beijing.

On April 16, 2025, the General Surgery Department of Shanghai Children's Hospital successfully performed the world's first Ladd procedure (corrective surgery for congenital intestinal malrotation) in a child using a domestically developed single-port laparoscopic robotic surgical (SP) system. This landmark achievement not only signifies a major breakthrough in the application of domestically developed intelligent surgical systems for complex pediatric minimally invasive interventions but also pioneers a transformative pathway for advancing minimally invasive approaches in high-difficulty pediatric surgeries.​

Recently, the Department of Urology at the National Children's Medical Center and Shanghai Children's Medical Center, affiliated with Shanghai Jiao Tong University School of Medicine, successfully performed a precise resection surgery for testicular tumor on a 6-month-old infant. This marked the 20th procedure conducted using the domestically developed Surui single-port robotic system since its clinical deployment in pediatric urology at the center earlier this year. Currently, this surgical technique is gaining recognition among pediatric surgeons and patient families for its "enhanced precision, minimized trauma, and optimized outcomes," receiving widespread acclaim and positive feedback.

Amidst the global surgical robotics sector's accelerated return to the essence of ultra-minimally invasive care, Beijing Shurui Robotics Co., Ltd., China's leading surgical robotics innovator, globally debuted its groundbreaking Variable Orifice Technology and the Ultra-Minimally Invasive Surgical Innovation Platform "Shurui^® S+suite" at the 91st China International Medical Equipment Fair (CMEF) on April 8, 2025.

At 2:00 a.m. on April 2, 2025, Beijing time, and 6:00 p.m. on April 1, 2025, Bucharest time, a remote surgery spanning 8,000 kilometers between China and Europe caused a stir in the global medical community. Professor Diego Gonzalez Rivas, a leading international thoracic surgeon, and his team from the University of Oxford, in collaboration with Professor Zhao Jun and his team from the First Affiliated Hospital of Soochow University (hereinafter referred to as "SUFU"), successfully performed a radical resection of a right 

In March 2025, the 40th European Association of Urology Annual Congress (EAU25) grandly opened in Madrid, Spain. As the most influential academic event in the global field of urology, this year's EAU gathered top experts, medical institutions, and innovative enterprises from more than 100 countries to jointly discuss the latest cutting-edge progress in urology.

Recently, the team led by Professor Zou Qiang and Professor Jin Yiting from the Department of General Surgery, Breast and Thyroid Surgery Center of Huashan Hospital Affiliated to Fudan University took the lead in using the domestic uniportal serpentine arm robotic technology to successively complete Shanghai's first uniportal robotic total mastectomy with immediate reconstruction and Shanghai's first uniportal robotic radical thyroidectomy. These procedures have opened up a brand-new direction for the diagnosis and treatment of thyroid and breast diseases in China.